ASO Visual Abstract: Phase II Prospective Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy with and without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels

Affiliations

• ¹ Section of General Surgery and Surgical Oncology, Department of Surgery, University of Chicago Medicine, Chicago, IL, USA.
• ² Section of Hematology/Oncology, Department of Medicine, University of Chicago Medicine, Chicago, IL, USA.
• ³ Department of Radiology, University of Chicago, Chicago, IL, USA.
• ⁴ Department of Radiation and Cellular Oncology, University of Chicago, Chicago, IL, USA.
• ⁵ The Ludwig Center for Metastasis Research, University of Chicago, Chicago, IL, USA.
• ⁶ Department of Public Health Sciences, University of Chicago, Chicago, IL, USA.
• ⁷ Section of General Surgery and Surgical Oncology, Department of Surgery, University of Chicago Medicine, Chicago, IL, USA. kturaga@surgery.bsd.uchicago.edu.